ATF6 and osteosarcoma: In relapsed/refractory osteosarcoma (OS), ATF6α cleavage and activity were enhanced in OS cells compared to normal osteoblasts, and knockdown of ATF6α expression sensitized OS cells to chemotherapeutic drugs and induced cell death by activating Bax [146] (Fig. 2).